2026-11-11 · 2026-11 / week-2
The Trade Desk’s Q3 slowdown is real; the short still fails 10/5
The Trade Desk’s Q3 slowdown is real; the short still fails 10/5
Classification: Reject / no trade. Q3 revenue slipped 0.5% year over year, Adjusted EBITDA fell 16%, and GAAP operating income fell 43%. Yet TTD held $1.65B in cash and short-term investments, had $745M of undrawn revolving availability, and its first regular session after earnings closed up 3.28%. At $15.42, the 36-analyst mean target gives only 8.6% short-side upside while the high target implies 29.7% adverse risk.
Run scope: U.S. market, short opportunities only; exactly one article.
Publication time: November 11, 2026, 17:07 Singapore time (09:07 UTC; 04:07 a.m. ET).
Quote cutoff: The model uses StockAnalysis/S&P Global’s completed Nov. 10 regular close of $15.42 at 4:00 p.m. ET. Separate observations: $15.30 after hours at 7:59 p.m. Nov. 10 and $15.37 pre-market at 4:00 a.m. Nov. 11. Both are reference context only; the $15.37 snapshot was seven minutes old at publication. [4]
Opportunity Ranking
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | The Trade Desk (TTD) | Short screen | Q3 revenue fell 0.5% and Adjusted EBITDA fell 16%, but 9M operating cash flow was positive, the first post-report close rose 3.3%, and the company authorized up to $1B of future repurchases. | Nov. 10 Form 10-Q and Nov. 9 earnings release; Nov. 10 close. | Q4 FY26 results; exact date not verified. | 72.29M shares short, 17.28% of provider float, Oct. 30 settlement; count fell 13.05% from Oct. 15. | Reject: analyst-mean base is -8.6%; high-target stress is +29.7%; base/adverse is 0.29:1. | Liquid listing, but current locate, borrow, spread, depth and exit capacity are unverified. | Cash, client retention, Netflix/CTV distribution and discretionary buybacks can support a recovery. |
| 2 | Rigetti Computing (RGTI) | Short screen | Q3 revenue fell 27.5% year over year and the $20M FY26 outlook depends on C-DAC acceptance, but cash and investments were $497M with no debt; analyst targets all exceed the regular close. | Nov. 10 Q3 release and Form 10-Q; latest reported short interest Oct. 30. | C-DAC system acceptance and associated Q4 revenue recognition; exact date not verified. | 68.29M shares short, 20.82% of provider float, Oct. 30 settlement; down 3.88% from Oct. 15. | Reject: no evidence-based downside bound; customer acceptance, a $100M Commerce agreement and quantum milestones create substantial squeeze risk. | Highly volatile; no short execution evidence. | A contract milestone or technical announcement can reprice the stock despite low current sales. |
| 3 | Firefly Aerospace (FLY) | Short screen | Q3 revenue rose 259% and backlog reached $1.7B, though nine-month free cash flow was -$270M. Cash/investments exceeded financial debt, and a post-quarter AST agreement carries conditional cash and share consideration. | Nov. 10 Q3 release and Form 10-Q; Oct. 30 short-interest settlement. | Launch cadence, milestone collections and AST agreement performance; no single dated downside catalyst verified. | 12.88M shares short, 8.88% of provider float, Oct. 30 settlement. | Reject: growth, backlog and conditional AST consideration leave upside unbounded; short payoff not established. | Irregular space-launch liquidity; locate and exit capacity not checked. | Program awards, launch execution or AST milestones can reprice the stock higher. |
| 4 | SPDR S&P 500 ETF (SPY) | Market control | Broad-market reference only; no index-specific short disagreement is established. | Nov. 10 regular close. | None specific to this screen. | Not used to infer positioning. | No standalone short thesis. | Broad ETF; execution not assessed. | A market rebound can lift single-name shorts. |
Selected opportunity: TTD ranks first for information value, not as an executable or 10/5-qualified short.
Why this one now: The Q3 filing turns the prior slowdown concern into an actual revenue contraction and a large GAAP earnings decline. It also reveals a new option repricing, lower year-to-date repurchases and a fresh $1B authorization. The August TTD mention was only a Q2 candidate in an AppLovin long screen; it had no standalone TTD thesis or signal. This screen uses Q3 results, the Nov. 10 first post-report close and the new capital-action disclosures. [1][2][20]
What should surprise the reader: Q3 revenue declined while the balance sheet strengthened. The release shows a nine-month cash-flow increase, but a $675M receivables cash inflow explains much of that improvement. Meanwhile, the new buyback authorization is not a purchase, and 14.4M employee options were repriced without changing their count or vesting. These separate states leave both the short thesis and the recovery case incomplete. [2]
Why TTD Ranks First for Information Value
Discovery compared three different mechanisms: an ad platform’s revenue, margin and share-supply reset (TTD); a quantum-computing vendor’s lumpy system acceptance, cash runway and milestone funding (RGTI); and a launch/spacecraft company’s backlog, cash burn and conditional customer consideration (FLY). SPY is the market control. TTD ranks first because its operating, cash, capital and post-result price evidence is most complete and internally testable. No candidate passes the short screen. [1][2][10][11][14][15][20]
TTD’s prior Q2-based comparison appears in the August AppLovin note, which discussed TTD as a cash-rich ad-tech alternative. The current issuer evidence changes the boundary: Q3 revenue moved from 3% year-over-year growth in Q2 to a 0.5% decline, Q3 Adjusted EBITDA margin fell to 36% from 43%, and the Q4 outlook supplies only minimum figures. The fresh 10-Q adds the Oct. 19 repricing of 14.4M options and post-quarter repurchase authorization. This is more than a refreshed quote or a renamed version of the Q2 comparison. [2][20]
Prior Forecast Review
No additional U.S. regular-session close has occurred since the prior run’s forecast audit. The previous screen recorded HIMS and WIX first-session outcomes and an ONON price-acceptance checkpoint. CRWV and LQDA reported after the Nov. 10 close; their first post-result regular sessions have not opened at this cutoff. No new target outcome, position or realized P&L is claimed. [20]
Why This Can Move More Than 5%
The first completed session after the Nov. 9 after-close release rose 3.28%, from $14.93 to $15.42. That close followed an intraday range of $14.30-$15.80 on roughly 65M shares. The move is not proof that the Q3 slowdown is resolved, but it shows the event can reprice the stock in both directions. TTD still has 17.28% of provider float reported short, although the Oct. 30 count was down 13.05% from Oct. 15. [4][5][6]
The next operating test is Q4 FY26. The company guided to at least $755M revenue and at least $280M Adjusted EBITDA. Q4 2025 revenue was $846.8M, so the Q4 revenue floor is 10.8% below that prior result if achieved exactly; it is not a ceiling or a point forecast. Q4 delivery, 2027 growth expectations, CTV integrations, share repurchases and short covering can all move the stock beyond the analyst range. The exact next reporting date is not verified. [1][3]
10/5 Asymmetry Gate
The map uses the $15.42 Nov. 10 regular close as a reference only and a 12-month horizon to Nov. 11, 2027. StockAnalysis/S&P Global lists 36 analyst targets with a $14.10 mean, $9 low and $20 high. These are secondary estimates, not fair value, guaranteed bounds or independently calibrated outcomes. [4][7]
- Highest-probability base decline: $15.42 to $14.10, or 8.6%, below the 10% hurdle.
- Credible adverse rise: $15.42 to $20, or 29.7%, far above the 5% limit.
- Base/adverse reward-to-risk: ($15.42-$14.10)/($20-$15.42) = 0.29:1, below 2:1.
- Top/adverse stress ratio: ($15.42-$9)/($20-$15.42) = 1.40:1, also below 2:1.
- Probability-weighted price: $14.85 using subjective 20% / 50% / 30% weights. Gross price-only short return is +3.7% before costs.
- Sensitivity: moving 10 percentage points from the base case to the $20 adverse case raises expected price to $15.44 and turns gross short value slightly negative, before costs.
- Status: Reject / no trade. The reference is not an executable entry; even the average target fails the base-return hurdle, and the adverse case is not bounded.
What Should Surprise the Reader
The Q3 report did not describe a balance-sheet crisis. It reported $1.23B cash, $420M short-term investments, an undrawn $745M revolving facility, and $804M of nine-month operating cash flow. The short thesis therefore rests on weak growth and declining earnings durability, not an immediate funding shortfall. [2]
The share actions cut both ways. TTD repurchased 10M shares for $233M in the first nine months, but reported no Class A repurchases in Q3. Its board then authorized another $731M, bringing future authorization to $1B. That authorization can support demand, but it is discretionary. [2]
The 10-Q also says roughly 14.4M employee and executive options were repriced to $12.26, with original exercise prices between $12.72 and $122.23. A six-month premium period reverts an option to its original strike if exercised or if the holder leaves during the period, subject to the stated exception. Share counts, vesting schedules and expiry dates did not change. These options are not issued shares or immediate float; exercise, vesting and any incremental compensation expense remain conditional or incomplete. At 14.4M, the eligible option count is about 3% of the Oct. 31 common-share count, a potential claim rather than a current denominator addition. [2]
The Setup
Operating bridge. Q3 revenue was $735.965M versus $739.433M a year earlier (-0.5%). Nine-month revenue still grew 4.4% to $2.140B. GAAP operating income fell 42.6% to $92.606M, net income fell 67.1% to $38.050M, and Adjusted EBITDA fell 16.3% to $265.837M. Adjusted EBITDA margin was 36% versus 43%. The company excluded $44.3M of 2026 restructuring charges from its non-GAAP Adjusted EBITDA; GAAP operating income shows the full cost in the quarter. [1][2]
Cash bridge. Nine-month operating cash flow rose 18% to $803.668M. Accounts receivable fell from $3.770B at Dec. 31 to $3.076B at Sept. 30, and the cash-flow statement records a $674.792M receivables inflow versus a $149.053M use in the prior-year period. Cash collection timing materially aided current-period cash flow. The Desk’s cash-after-capex proxy is $565.356M: $803.668M CFO less $226.745M property/equipment purchases and $11.567M capitalized software, before $33.513M asset-sale proceeds. It is not a company-defined free-cash-flow measure. [2]
Guide bridge. Q4 revenue guidance is a floor of $755M and Adjusted EBITDA a floor of $280M. Adding the revenue floor to nine-month actuals gives $2.895B FY26 revenue, roughly flat with FY25’s $2.896B if the quarter lands at the floor. This is Desk arithmetic, not a company full-year forecast. The at-least wording allows a higher result. The company says no forward GAAP net-income reconciliation is available without unreasonable efforts because stock-based compensation can vary with the share price. [1][2]
The Market Price
StockAnalysis/S&P Global reports the Nov. 10 regular close at $15.42, +$0.49 (+3.28%), with a $14.30-$15.80 range and 64,966,772 shares. ChartExchange reports $15.43, +3.35%, and 64,869,437 shares, with slightly different open and low. The two sources are not averaged. StockAnalysis showed $15.30 at 7:59 p.m. after hours on Nov. 10 and $15.37 at 4:00 a.m. pre-market on Nov. 11; ChartExchange’s earlier after-hours snapshot was $15.33 at 4:59 p.m. Nov. 10. These observations have different times and are not executable quotes. SPY closed at $749.91, down 0.37%. [4][5][19]
At $15.42 and StockAnalysis’s 472.89M share snapshot, the implied equity value is about $7.29B. The 10-Q reports $1.229B cash, $420M short-term investments, $581M operating lease liabilities, no revolving balance and $745M of available revolver capacity. A Desk EV proxy of $6.22B follows: $7.292B equity - $1.650B cash/investments + $0.581B leases. TTM revenue is $2.987B, calculated as FY25 revenue $2.896B + nine-month 2026 revenue $2.140B - nine-month 2025 revenue $2.049B. The resulting EV/TTM-sales proxy is 2.08x. This is a mixed-date reference, not fair value. [2][3][8]
The Mispricing
The price is not obviously high against current sales and net cash. The bearish disagreement is about durability: Q3 revenue slipped, GAAP operating income fell 43%, and the Q4 revenue floor is below last year’s actual quarter. The counter-case is that nine-month revenue grew, cash generation was positive, client retention remained above 95% by company disclosure, and CTV integrations with Netflix are expanding. The first regular session after earnings rose rather than fell. [1][2][4]
I do not claim a verified market-implied probability for a growth reset. The analyst page shows a Hold rating, a $14.10 mean and a wide $9-$20 target range. The same page’s annual revenue estimate of $2.84B for FY26 is below the issuer’s arithmetic floor of about $2.895B from nine-month actuals plus Q4 minimum guidance. Its estimate update time is not visible, so I exclude that $2.84B figure from the valuation bridge. The unresolved estimate conflict weakens, rather than strengthens, a precise short thesis. [1][7]
The Positioning
ChartExchange’s FINRA-sourced table reports 72,291,944 shares short, 17.28% of its 418.426M float and 5.55 days to cover at Oct. 30 settlement. The count fell 10,846,513 shares (-13.05%) from Oct. 15, before the Q3 report. This is still a large reported short, but positions were shrinking before the result; it is not evidence of current borrow conditions or forced covering. No current borrow fee, utilization, recall terms, options concentration, spread, depth or exit capacity was verified. [6]
The Catalyst
- Q4 FY26 report. Exact date not verified. Test whether revenue and Adjusted EBITDA exceed the issuer floors of $755M and $280M, then reconcile GAAP operating income, receivables, CFO, share count, repurchases and the repriced options.
- Netflix and CTV integration. TTD says Netflix targeting using first- and third-party data became available through Kokai beginning in November; performance and advertiser spend conversion have not been reported. [1]
- Repurchase program and option repricing. Verify actual repurchases, option vesting/exercise and any measured incremental stock-compensation cost. The authorization itself is not executed share demand. [2]
The cheapest disconfirming test is the next filed quarter: does revenue return to growth while cash flow remains positive after receivables balances stabilize and buybacks actually occur? Do not short just because a report contains negative year-over-year lines.
The Payoff
The modeled instrument is unlevered TTD common stock, for research only. The scenario map uses secondary 12-month analyst target markers as external stress anchors and keeps the analyst mean as the base proxy. It does not model borrow cost, dividends, recall, the timing of buybacks, options exercise or a CTV-driven re-rating. None of those omissions creates a short edge; they widen the uncertainty.
Price Target and Probability Map
| Scenario | Probability | Target / Level | Return / Payoff | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case | 20% | $9.00 | +41.6% underlying short return | Through Nov. 11, 2027 | S&P Global/StockAnalysis analyst-low stress; growth reset persists and valuation falls | Low |
| Base Case | 50% | $14.10 | +8.6% underlying short return | Same | Analyst-mean reference; revenue stays weak but cash and buyback capacity persist | Low |
| Bottom Case | 30% | $20.00 | -29.7% underlying short return | Same | Analyst-high stress; CTV/Netflix, strong cash flow and repurchases support a re-rating or squeeze | Low |
| Invalidation | n/a | Revenue and Adjusted EBITDA reaccelerate while receivables stabilize and repurchases reduce shares without renewed compression in operating margin | Retire this short screen; rebuild from a current quote and filed denominator | Next quarterly filings; exact date not verified | Operating traction and capital return become observed, not merely authorized | Medium |
Probability-weighted expected value: $14.85 per share; +3.7% gross price-only short return before borrow, spread, slippage, fees and carrying cost. Probabilities are subjective estimates, not observed frequencies.
Current market level and timestamp: $15.42 regular close, Nov. 10, 2026 at 4:00 p.m. ET.
Primary instrument: TTD Class A common stock; no trade proposed.
10/5 favorable base move: 8.6%, below the 10% threshold.
10/5 credible adverse move: 29.7% rise to the analyst-high stress; upside is not capped at $20.
10/5 measurement basis: Reference-only; no verified executable entry.
10/5 status: Reject.
Confidence: Low. The analyst range is secondary, borrow terms and exit capacity are absent, and the near-flat revenue floor has not yet been reported as actual revenue.
The Kill Shot
The strongest counterargument is that the business has not lost its platform economics. Client retention stayed above 95% for more than a decade by company report, nine-month revenue rose 4.4%, the company generated $804M of nine-month CFO and ended September with $1.65B in cash and short-term investments. Netflix targeting and new measurement tools may convert into advertiser spend; the board can use buybacks if it believes the shares are undervalued. The Nov. 10 close rose 3.28% after the report. These facts leave a real squeeze path. [1][2][4]
The most fragile short assumption is that one quarter of slightly lower revenue starts a durable share-loss cycle. The Q3 release does not prove that. Nor does a single positive close prove recovery. The next results must show whether revenue, margin and client activity improve, while the 10-Q’s cash-flow bridge tests whether collections can normalize without reducing cash generation.
What Could Go Wrong
Short losses can exceed the $20 analyst-high marker. A return to double-digit growth, stronger CTV budgets, Netflix monetization, actual buyback activity, option-related compensation changes, analyst upgrades, or a market rally can lift TTD. The Oct. 30 short-interest count is stale and declining; it cannot measure recall or borrow supply today. Gaps, halts and unavailable exits can bypass any planned stop.
The opposite error is treating the Q3 decline as cosmetic. Operating income fell 43%, net income 67%, and the company’s annual revenue floor from Q4 minimum guidance is essentially flat with FY25 if the minimum is met. Receivables collections powered much of the nine-month CFO increase, and Q4 floor revenue is lower than last year’s actual quarter. If spend shifts from TTD to rival platforms or the Q4 result only meets the floor, the slowdown may persist.
What Would Prove This Wrong
Retire the short screen if the next filings show revenue above the Q4 minimum, improving GAAP operating margin, customer retention and CTV spend growth, while operating cash flow remains positive after receivables stabilize and completed repurchases reduce the share count. Rebuild from current filings, option exercise state, short positioning and a fresh regular-session price. A lower price alone does not prove the operating thesis.
Risk Audit
| Risk | Treatment |
|---|---|
| Growth | Q3 revenue -0.5% y/y; nine-month revenue +4.4%. One quarter is not yet a durable trajectory. |
| Profitability | GAAP operating income -42.6%; Adjusted EBITDA -16.3%; Adjusted EBITDA excludes $44.3M of restructuring charges. |
| Cash quality | 9M CFO rose, but the $674.8M receivables inflow is a large working-capital contributor. |
| Capital return | $1B authorization is not an executed purchase; Q3 repurchases were zero and 9M actual retired shares were 10M. |
| Option claims | 14.4M options repriced; counts and vesting unchanged; premium reversion and exercise remain conditional. |
| Positioning | Oct. 30 short interest is stale and had declined; current borrow and recall are unknown. |
| Valuation | 2.08x EV/TTM-sales is a mixed-date Desk reference, not fair value; analyst targets are not a downside bound. |
| Execution | No fresh pre-market quote, live spread, depth, venue/volume quality, locate, borrow cost or exit capacity verified. |
Best Trade Strategy
No trade. Do not short from the $15.42 close or treat the $9 analyst-low marker as a floor. Entry remains null and execution blocked. Reopen only after a current regular-session quote, updated borrow/recall and liquidity data, and a new model show at least a 10% base decline, credible upside within 5%, 2:1 base/adverse reward-to-risk and positive expected value after costs. The repriced options and $1B authorization must be reconciled as actual actions before changing the denominator or cash bridge.
Sources
- The Trade Desk Q3 2026 results, SEC Exhibit 99.1 - Q3 and nine-month results, guidance, customer/CTV details and new authorization.
- The Trade Desk Q3 2026 Form 10-Q - cash, investments, leases, operating cash flow, repurchases, option repricing and share counts.
- The Trade Desk Q4 and FY2025 results - FY25 and Q4 2025 revenue comparison.
- TTD Nov. 10 price history, StockAnalysis/S&P Global - regular close, OHLC, volume and later after-hours/pre-market marks.
- TTD Nov. 10 price history, ChartExchange - independent close/range/volume and earlier after-hours snapshot; not averaged.
- TTD official short-interest table, ChartExchange - Oct. 30 settlement, shares short, float and days-to-cover.
- TTD 12-month analyst targets, StockAnalysis/S&P Global - 36-analyst range and Nov. 10 target updates; stress anchors, not fair value.
- TTD statistics and valuation, StockAnalysis/S&P Global - market capitalization, enterprise value, shares and TTM metrics.
- Prior TTD Q2 comparison, August AppLovin screen - Q2 evidence boundary; TTD was a comparison only, not a standalone signal.
- Rigetti Q3 2026 results, SEC Exhibit 99.1 and Q3 Form 10-Q - candidate revenue, cash, C-DAC, technical milestone and funding conditions.
- RGTI Nov. 10 price history, StockAnalysis and official short-interest table, ChartExchange - regular close, after-hours reference and Oct. 30 settlement positioning.
- RGTI analyst targets, StockAnalysis/S&P Global - target range as secondary counterparty evidence, not fair value.
- Firefly Q3 2026 results, SEC Exhibit 99.1 and Q3 Form 10-Q - candidate backlog, cash, debt, cash burn and conditional AST agreement.
- FLY Nov. 10 price history, StockAnalysis and official short-interest table, ChartExchange - first post-result close and Oct. 30 short-interest settlement.
- FLY analyst targets, StockAnalysis/S&P Global - candidate target range; not fair value or a price bound.
- SPY Nov. 10 price history, ChartExchange - broad-market control.
Research Quality Scorecard
| Criterion | Score | Evidence and deduction |
|---|---|---|
| Market disagreement | 4/5 | Q3 contraction and weaker margins conflict with positive cash, high retention, buyback capacity and a positive first-session close. |
| Evidence base | 4/5 | Current SEC 10-Q and release plus timestamped market data; full-year consensus estimates conflict with issuer guidance and are excluded. |
| Positioning and flows | 3/5 | Oct. 30 SI is meaningful but stale and declining; borrow, utilization, recalls and fund flows are unknown. |
| Catalyst path | 3/5 | Q4 guide and CTV integrations can be tested, but exact next report date and revenue conversion are unverified. |
| Payoff architecture | 2/5 | Analyst-mean base is only -8.6%, adverse high case +29.7%, ratio 0.29:1; before costs. |
| Invalidation discipline | 4/5 | Q4 revenue, EBITDA, receivables, margin, buybacks and option exercises are observable. |
| Differentiated insight | 4/5 | The Q4 floor implies near-flat FY revenue if met at the floor; analyst full-year revenue snapshot sits below that arithmetic floor. |
| Client value | 5/5 | Separates authorized buyback and option repricing from actual share issuance/repurchase while rejecting a fragile short. |
| Total | 29/40 | Reject remains required because 10/5 fails; quality score is not a trade rating. |
Bottom Line
TTD’s Q3 proves that growth and margins slowed, but not that the stock has another 10% downside leg. The company has cash, positive operating cash flow and flexible buyback capacity; it also has lower revenue, lower EBITDA and a disclosed option repricing. At $15.42, the analyst-mean target gives only 8.6% short upside, the adverse high target is +29.7%, and the probability-weighted gross return is 3.7% before costs. Reject; no trade.
AI Illustration Prompt
Create a restrained financial-editorial illustration of an advertising auction viewed through two ledgers. One ledger shows “Q3 revenue -0.5% / Adjusted EBITDA -16%” while a second shows “$1.65B cash + short-term investments / $1B buyback authorization.” Between them, place a small, transparent option sheet marked “14.4M repriced / not issued,” with the six-month condition visible as a bracket rather than a price arrow. In the background, a quiet CTV screen shows audience tiles with no logos. Use graphite, warm paper, muted cobalt and one restrained amber accent. No ads, tickers, price calls, rockets or trading commands. Add a subtle readable “The Mispricing Desk” watermark at lower right.